2017 Press Releases

Keyword Search
2017 | 2016 | 2015 | 2014 | 2013
01/19/17Seattle Genetics to Host Conference Call and Webcast Discussion of Fourth Quarter and Year 2016 Financial Results on February 9, 2017
BOTHELL, Wash.--(BUSINESS WIRE)--Jan. 19, 2017-- Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it will report its fourth quarter and year 2016 financial results on Thursday, February 9, after the close of financial markets. Following the results announcement, company management will host a conference call and webcast discussion of the results and provide a general corporate update. Access to the event can be obtained as follows: ... 
Printer Friendly Version
01/05/17Seattle Genetics Initiates Phase 1 Trial of SGN-CD352A for Patients with Relapsed or Refractory Multiple Myeloma
-SGN-CD352A, a Novel Antibody-Drug Conjugate (ADC), Represents Seattle Genetics’ 9th Clinical Stage Program in a Robust Pipeline of Empowered Antibody Therapies- -Preclinical Data Showing Potent Antitumor Activity of SGN-CD352A in B-cell Cancers Presented at the 2016 American Association of Cancer Research Annual Meeting- BOTHELL, Wash.--(BUSINESS WIRE)--Jan. 5, 2017-- Seattle Genetics, Inc. (NASDAQ: SGEN), a global biotechnolog... 
Printer Friendly Version